Tempest Therapeutics
Business Services · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2000 Sierra Point Pkwy Ste 400, Brisbane...Phone Number
(415) 798-8589Website
www.tempesttx.comRevenue
-Stock Symbol
TPSTIndustry
About Tempest Therapeutics
Tempest Therapeutics is a clinical-stage biotechnology company headquartered in Brisbane, California, and publicly traded on Nasdaq under the ticker TPST. The company develops next-generation in vivo CAR-T therapies for autoimmune diseases and cancer, using a proprietary mRNA lipid nanoparticle delivery platform. Its pipeline includes TPST-4003, a dual-target CD19/BCMA CAR-T therapy, and TPST-2003, a similar therapy being developed for relapsed/refractory multiple myeloma in partnership with Novatim Immune Therapeutics. Tempest is also exploring applications in conditions such as myasthenia gravis and multiple sclerosis.Explore more
SIC Code 28,283NAICS Code 32,325Ticker NASDAQ: TPSTShow moreTempest Therapeutics Org Chart
Compare Similar Companies to Tempest Therapeutics
Compare insights from companies similar to Tempest Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Tempest Therapeutics Tech Stack
A closer look at the technologies used by Tempest Therapeutics
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Tempest Therapeutics
Sign Up For FreeTo access detailed company insights
Tempest Therapeutics is a clinical-stage biotechnology company headquartered in Brisbane, California, and publicly traded on Nasdaq under the ticker TPST. The company develops next-generation in vivo CAR-T therapies for autoimmune diseases and cancer, using a proprietary mRNA lipid nanoparticle delivery platform. Its pipeline includes TPST-4003, a... Read More
